OXB — Oxford BioMedica Share News
0.000.00%
Last trade - 00:00- £616.15m
- £699.51m
- £168.74m
Brief: Oxford BioMedica H1 Revenue GBP 73.2 Million
Interim Results for 6 months ended 30 June 2025
PDMR Dealings
Holding(s) in Company
PDMR Dealings
Brief: Oxford Biomedica Says Placement & Subscription Raised £60 Mln
Results of Placing
Brief: Oxford Biomedica Expects FY2026 Revenues To Reach £220-£240 Mln
Proposed Placing of New Ordinary Shares
Brief: Oxford Biomedica Secures Up To $125 Million Loan Facility
UK's Oxford Biomedica sees first-half sales surging on strong order book (updated)
UK's Oxford Biomedica maintains annual outlook
Brief: Oxford Biomedica Reiterates FY25 Rev Guidance
Half Year Trading Update
Europe Research Roundup: CVS, Orsted, Rio Tinto
Director Declaration
Director/PDMR Shareholding
Brief: Oxford Biomedica Expects To Deliver Outlook Set Out In Preliminary Results For Year Ended 31 Dec
AGM Update